vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and TPG Mortgage Investment Trust, Inc. (MITT). Click either name above to swap in a different company.
TPG Mortgage Investment Trust, Inc. is the larger business by last-quarter revenue ($20.4M vs $13.8M, roughly 1.5× Gossamer Bio, Inc.). TPG Mortgage Investment Trust, Inc. runs the higher net margin — 65.0% vs -342.3%, a 407.3% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 17.7%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
TPG Mortgage Investment Trust, Inc. is a real estate investment trust managed by global alternative asset firm TPG. It primarily invests in residential and commercial mortgage-backed securities, performing and non-performing mortgage loans, and other credit-linked real estate assets, with its core market being the United States. It generates returns via net interest income from holdings and strategic asset disposition gains.
GOSS vs MITT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $20.4M |
| Net Profit | $-47.2M | $13.3M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 67.1% |
| Net Margin | -342.3% | 65.0% |
| Revenue YoY | 47.1% | 17.7% |
| Net Profit YoY | -43.0% | -7.0% |
| EPS (diluted) | $-0.21 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $20.4M | ||
| Q3 25 | $13.3M | $19.5M | ||
| Q2 25 | — | $17.8M | ||
| Q1 25 | — | $18.8M | ||
| Q4 24 | — | $17.4M | ||
| Q3 24 | — | $14.9M | ||
| Q2 24 | $95.8M | $16.4M | ||
| Q1 24 | $0 | $17.2M |
| Q4 25 | $-47.2M | $13.3M | ||
| Q3 25 | $-48.2M | $20.0M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $11.5M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $16.6M | ||
| Q2 24 | $49.2M | $3.9M | ||
| Q1 24 | $-41.9M | $20.9M |
| Q4 25 | -333.6% | 67.1% | ||
| Q3 25 | -369.4% | — | ||
| Q2 25 | — | 20.9% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | — | 76.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | 54.3% | 18.4% | ||
| Q1 24 | — | — |
| Q4 25 | -342.3% | 65.0% | ||
| Q3 25 | -362.7% | 102.5% | ||
| Q2 25 | — | 22.2% | ||
| Q1 25 | — | 60.9% | ||
| Q4 24 | — | 82.2% | ||
| Q3 24 | — | 111.3% | ||
| Q2 24 | 51.4% | 24.0% | ||
| Q1 24 | — | 121.6% |
| Q4 25 | $-0.21 | $0.27 | ||
| Q3 25 | $-0.21 | $0.47 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $0.30 | ||
| Q3 24 | — | $0.40 | ||
| Q2 24 | $0.22 | $-0.02 | ||
| Q1 24 | $-0.19 | $0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $57.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $560.7M |
| Total Assets | $172.2M | $8.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $57.8M | ||
| Q3 25 | $180.2M | $59.0M | ||
| Q2 25 | — | $88.7M | ||
| Q1 25 | — | $115.5M | ||
| Q4 24 | — | $118.7M | ||
| Q3 24 | — | $102.5M | ||
| Q2 24 | $354.5M | $120.9M | ||
| Q1 24 | $244.4M | $100.3M |
| Q4 25 | $-122.8M | $560.7M | ||
| Q3 25 | $-82.3M | $559.8M | ||
| Q2 25 | — | $536.4M | ||
| Q1 25 | — | $543.9M | ||
| Q4 24 | — | $543.4M | ||
| Q3 24 | — | $540.1M | ||
| Q2 24 | $81.5M | $533.5M | ||
| Q1 24 | $26.7M | $539.6M |
| Q4 25 | $172.2M | $8.7B | ||
| Q3 25 | $208.8M | $9.0B | ||
| Q2 25 | — | $7.5B | ||
| Q1 25 | — | $7.3B | ||
| Q4 24 | — | $6.9B | ||
| Q3 24 | — | $7.0B | ||
| Q2 24 | $373.4M | $7.1B | ||
| Q1 24 | $259.4M | $6.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $59.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 4.48× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $59.6M | ||
| Q3 25 | $-36.2M | $17.4M | ||
| Q2 25 | — | $11.5M | ||
| Q1 25 | — | $12.0M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | $116.3M | $13.7M | ||
| Q1 24 | $-52.3M | $12.0M |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.48× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 2.92× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | 3.91× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | 2.36× | 3.50× | ||
| Q1 24 | — | 0.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
